Search Results 1611-1620 of 21603 for biopsy

1. A Study of Course and Treatment Outcomes of Paraneoplastic Neurological Disorders and Other CNS Inflammatory Disorders - Mayo Clinic

   Patients with inflammatory neurological diseases who have had biopsies done. ... Patients that do not have inflammatory CNS disorders and have not had a biopsy ...

2. Gastrointestinal Disorders Clinical Trials - Mayo Clinic Research

   ... Biopsy Specimens. Rochester, MN. The purpose of this study is to ... biopsies, examine any change in gastrointestinal symptom score as estimated by a ...

3. A Study to Evaluate the Safety and Effectiveness of CAEL-101 and Plasma Cell Dyscrasia Treatment vs. Placebo and Plasma Cell Dyscrasia Tretment to Treat Patients with Mayo Stage IIIb AL Amyloidosis - Mayo Clinic

   Endomyocardial biopsy demonstrating AL cardiac amyloidosis or ii. ... biopsy (performed ≤ 3 months prior to signing the ICF) or biopsy-proven (performed ...

4. Staging of Superficial EAC Using VLE - Mayo Clinic

   Patients who require anticoagulation for who biopsy would be contraindicated; Patients who are known to be pregnant. Participating Mayo Clinic locations. Study ...

5. Usefulness of Controlled Attenuation Parameter (CAP) for the Assessment of Liver Steatosis - Mayo Clinic

   The primary aim of this study is to determine the accuracy of CAP from Fibroscan in the quantification of liver steatosis in donors using liver biopsies as the ...

6. COPD Clinic - Overview

   CT scan; Endobronchial ultrasound biopsy; Endoscopic lung volume reduction surgery; Inhalers; In-home noninvasive ventilation therapy; Lung (pulmonary) function ...

7. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   ... biopsy, Conization, Intrauterine device method, Hysteroscopy, Vaginectomy, Vulvectomy, Pelvic tumor surgery, Ovarian remnant removal, Salpingectomy ...

8. A Study to Compare Positron Emission Mammography with Contrast-Enhanced Breast MRI for Detecting Breast Cancer - Mayo Clinic

   ... biopsy-proven malignancy (BI-RADS Category 5 or 6 within 60 days prior to ... Have contraindications to the clinical MRI examination; Scheduled to undergo breast ...

9. Identifying Gene Modifiers of Melanoma and Pancreatic Cancer Susceptibility - Mayo Clinic

   Participation eligibility ; Inclusion Criteria (Cases):. Must be a known mutation carrier of CDKN2A. · Able and willing to provide a skin biopsy. ; Inclusion ...

10. Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer - Mayo Clinic

    ... biopsy are still eligible to participate in this study; Estrogen receptor positive disease is defined as > 10% nuclear staining; HER2 negative disease as per ...